Hassan Lemjabbar-Alaoui
Overview
Explore the profile of Hassan Lemjabbar-Alaoui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
740
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brand N, Yang Y, Ding V, Dutta H, Peto C, Lemjabbar-Alaoui H, et al.
Am J Cancer Res
. 2024 Feb;
14(1):378-389.
PMID: 38323288
Esophageal cancer is one of the leading causes of cancer deaths globally with an incidence that is concentrated in specific hot spots in Eastern Asia, the Middle East, Eastern Africa,...
2.
Yang Y, Jablons D, Lemjabbar-Alaoui H
Exp Lung Res
. 2021 Apr;
47(6):261-279.
PMID: 33908819
Purpose: Non-small lung (NSCLC) is the deadliest cancer, with survival measured in months. Earlier diagnosis using a robust biomarker would likely improve survival. This study aims to determine whether blood...
3.
Luo X, Campbell N, He L, OBrien D, Singer M, Lemjabbar-Alaoui H, et al.
Hepatology
. 2021 Mar;
74(3):1411-1428.
PMID: 33735525
Background And Aims: Existing therapeutic approaches to treat cholangiocarcinoma (CCA) have limited effectiveness, prompting further study to develop therapies for CCA. We report a mechanistic role for the heparan sulfate...
4.
Yang Y, Phillips J, Jablons D, Lemjabbar-Alaoui H
Biochim Biophys Acta Gen Subj
. 2020 Dec;
1865(2):129802.
PMID: 33276062
Background: Cell-surface heparan sulfate proteoglycans (HSPGs) function as receptors or co-receptors for ligand binding and mediate the transmission of critical extracellular signals into cells. The complex and dynamic modifications of...
5.
Yang Y, Marrufo A, Chase J, Woodard G, Jablons D, Lemjabbar-Alaoui H
Exp Lung Res
. 2020 Oct;
47(1):9-25.
PMID: 33107354
Purpose: Malignant pleural mesothelioma (MPM) is a rare and deadly malignancy. Current MPM therapies remain inadequate, and outcomes are often disappointing. New meaningful therapeutic approaches are urgently needed. Accumulating evidence...
6.
Lemjabbar-Alaoui H, Peto C, Yang Y, Jablons D
Am J Cancer Res
. 2020 Sep;
10(8):2649-2676.
PMID: 32905466
Poly (ADP-ribose) polymerase (PARP) has recently emerged as a central mediator in cancer resistance against numerous anticancer agents to include chemotherapeutic agents such as microtubule targeting agents and DNA damaging...
7.
Lui N, Yang Y, van Zante A, Buchanan P, Jablons D, Lemjabbar-Alaoui H
PLoS One
. 2016 Feb;
11(2):e0148911.
PMID: 26882224
Aims: Lung cancer is one of the most deadly cancers; median survival from diagnosis is less than one year in those with advanced disease. Novel lung cancer biomarkers are desperately...
8.
Lemjabbar-Alaoui H, Hassan O, Yang Y, Buchanan P
Biochim Biophys Acta
. 2015 Aug;
1856(2):189-210.
PMID: 26297204
Lung cancer remains the leading cause of cancer mortality in men and women in the U.S. and worldwide. About 90% of lung cancer cases are caused by smoking and the...
9.
Lemjabbar-Alaoui H, McKinney A, Yang Y, Tran V, Phillips J
Adv Cancer Res
. 2015 Mar;
126:305-44.
PMID: 25727152
Alterations in glycosylation are common in cancer and are thought to contribute to disease. Lung cancer and primary malignant brain cancer, most commonly glioblastoma, are genetically heterogeneous diseases with extremely...
10.
Singer M, Phillips J, Lemjabbar-Alaoui H, Wang Y, Wu J, Goldman R, et al.
Clin Chim Acta
. 2014 Dec;
440:72-8.
PMID: 25444749
Background: SULF2 is an extracellular sulfatase that acts on heparan sulfate proteoglycans and modulates multiple signaling pathways. It is normally bound to the cell surface but can be released into...